McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

224.26USD
2 Jul 2015
Change (% chg)

$-1.52 (-0.67%)
Prev Close
$225.78
Open
$226.79
Day's High
$226.95
Day's Low
$223.03
Volume
349,310
Avg. Vol
227,464
52-wk High
$243.61
52-wk Low
$178.30

MCK.N

Chart for MCK.N

About

McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technology. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and drugs and equipment and health and beauty care products throughout North America and internationally. This segment... (more)

Overall

Beta: 0.96
Market Cap(Mil.): $52,100.64
Shares Outstanding(Mil.): 232.32
Dividend: 0.24
Yield (%): 0.43

Financials

  MCK.N Industry Sector
P/E (TTM): 29.72 25.40 40.61
EPS (TTM): 7.54 -- --
ROI: 9.39 10.13 59.45
ROE: 21.49 11.35 66.48
Search Stocks

McKesson settles investigation on controlled substances

- U.S. drug wholesaler McKesson Corp said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.

30 Apr 2015

McKesson settles investigation on controlled substances

April 30 - U.S. drug wholesaler McKesson Corp said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.

30 Apr 2015

Omnicare draws buyout interest from CVS, Express Scripts: Bloomberg

- Pharmacy service provider Omnicare Inc is getting buyout interest from potential buyers, including Express Scripts Holding Co and CVS Health Corp , Bloomberg reported, citing people with knowledge of the matter.

30 Apr 2015

Omnicare draws buyout interest from CVS, Express Scripts - Bloomberg

April 30 - Pharmacy service provider Omnicare Inc is getting buyout interest from potential buyers, including Express Scripts Holding Co and CVS Health Corp, Bloomberg reported, citing people with knowledge of the matter.

30 Apr 2015

UPDATE 2-Higher prescription sales help Rite Aid beat profit estimates

April 8 - Rite Aid Corp reported a better-than-expected quarterly profit on Wednesday, and expected a renewed distribution agreement with McKesson Corp along with the remodeling of its wellness stores to benefit fiscal 2016 earnings.

08 Apr 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$169.00
Provider: Wright Reports
$169.00
Provider: Wright Reports
$169.00
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks